Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127874381 | 12787438 | 1 | I | 20160921 | 20160928 | 20160928 | EXP | CN-ROCHE-1833681 | ROCHE | REN Q, JU W, WANG D, GUO Z, CHEN M AND HE X. DIAGNOSIS AND TREATMENT OF PURE RED CELL APLASIA CAUSED BY HUMAN PARVOVIRUS B19 AFTER LIVER TRANSPLANTATION: REPORT OF ONE CASE AND LITERATURE REVIEW. CHINESE JOURNAL OF ORGAN TRANSPLANTATION 2016 MAR;37 (3):144-9. | 50.00 | YR | M | Y | 0.00000 | 20160928 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127874381 | 12787438 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | U | 50722 | ||||||||||
| 127874381 | 12787438 | 2 | SS | Daclizumab | DACLIZUMAB | 1 | Unknown | U | 0 | 50 | MG | ||||||||
| 127874381 | 12787438 | 3 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | U | 0 | 500 | MG | ||||||||
| 127874381 | 12787438 | 4 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | U | 0 | ||||||||||
| 127874381 | 12787438 | 5 | SS | SIROLIMUS. | SIROLIMUS | 1 | Unknown | U | 0 | ||||||||||
| 127874381 | 12787438 | 6 | SS | CICLOSPORIN A | CYCLOSPORINE | 1 | Unknown | U | 0 | ||||||||||
| 127874381 | 12787438 | 7 | C | HEPATITIS B IMMUNE GLOBULIN | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN | 1 | Intravenous drip | 0 | |||||||||||
| 127874381 | 12787438 | 8 | C | HEPATITIS B IMMUNE GLOBULIN | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN | 1 | Intravenous drip | 0 | |||||||||||
| 127874381 | 12787438 | 9 | C | HEPATITIS B IMMUNE GLOBULIN | HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN | 1 | Intravenous drip | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127874381 | 12787438 | 1 | Prophylaxis against transplant rejection |
| 127874381 | 12787438 | 2 | Prophylaxis against transplant rejection |
| 127874381 | 12787438 | 3 | Prophylaxis against transplant rejection |
| 127874381 | 12787438 | 4 | Prophylaxis against transplant rejection |
| 127874381 | 12787438 | 5 | Prophylaxis against transplant rejection |
| 127874381 | 12787438 | 6 | Prophylaxis against transplant rejection |
| 127874381 | 12787438 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127874381 | 12787438 | DE |
| 127874381 | 12787438 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127874381 | 12787438 | Aplasia pure red cell | |
| 127874381 | 12787438 | Lung infection | |
| 127874381 | 12787438 | Multiple organ dysfunction syndrome | |
| 127874381 | 12787438 | Parvovirus B19 infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |